Newstrail.com

Smart Inhalers Market Size Poised for Growth, Expected to Reach USD 1.1 billion by 2030

Newstrail

Allied Market Research published a report, titled, “Smart Inhalers Market by Product (Inhalers and Nebulizers), Indication (Asthma and COPD), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021โ€“2030″. According to the report, the global Smart Inhalers industry generated $118 million in 2020 and is anticipated to generate $1.1 billion by 2030, witnessing a CAGR of 25.1% from 2021 to 2030.

This report provides a comprehensive overview of the Smart Inhalers Market, including an in-depth analysis of market trends, key segments, investment opportunities, value chain analysis, regional landscape, and competitive scenarios. It offers valuable insights for established market players, new entrants, investors, and other stakeholders to devise effective strategies and make informed decisions to enhance their market position. The report is a valuable resource for anyone seeking to gain a deeper understanding of the Smart Inhalers Market and its growth potential in the future.

๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ž ๐ข๐ง ๐ญ๐จ๐›๐š๐œ๐œ๐จ ๐œ๐จ๐ง๐ฌ๐ฎ๐ฆ๐ฉ๐ญ๐ข๐จ๐ง ๐š๐ฆ๐จ๐ง๐  ๐ฆ๐ž๐ง ๐š๐ฌ ๐ฐ๐ž๐ฅ๐ฅ ๐š๐ฌ ๐ฐ๐จ๐ฆ๐ž๐ง ๐ข๐ง ๐๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ž๐ ๐œ๐จ๐ฎ๐ง๐ญ๐ซ๐ข๐ž๐ฌ ๐š๐ง๐ ๐ก๐ข๐ ๐ก๐ž๐ซ ๐ซ๐ข๐ฌ๐ค ๐จ๐Ÿ ๐ž๐ฑ๐ฉ๐จ๐ฌ๐ฎ๐ซ๐ž ๐ญ๐จ ๐ข๐ง๐๐จ๐จ๐ซ ๐š๐ข๐ซ ๐ฉ๐จ๐ฅ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐š๐ซ๐ž ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ข๐ง๐œ๐ซ๐ž๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐ฉ๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ซ๐ž๐ฌ๐ฉ๐ข๐ซ๐š๐ญ๐จ๐ซ๐ฒ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ž๐ช๐ฎ๐š๐ฅ๐ฅ๐ฒ ๐š๐ฆ๐จ๐ง๐  ๐›๐จ๐ญ๐ก ๐ฆ๐ž๐ง ๐š๐ง๐ ๐ฐ๐จ๐ฆ๐ž๐ง, ๐ฐ๐ก๐ข๐œ๐ก ๐๐ซ๐ข๐ฏ๐ž ๐ญ๐ก๐ž ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฌ๐ฆ๐š๐ซ๐ญ ๐ข๐ง๐ก๐š๐ฅ๐ž๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ. ๐‡๐จ๐ฐ๐ž๐ฏ๐ž๐ซ, ๐ญ๐ก๐ž ๐ซ๐ข๐ฌ๐ค ๐จ๐Ÿ ๐๐š๐ญ๐š ๐ฅ๐ž๐š๐ค๐š๐ ๐ž ๐ก๐ข๐ง๐๐ž๐ซ๐ฌ ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก. ๐Ž๐ง ๐ญ๐ก๐ž ๐จ๐ญ๐ก๐ž๐ซ ๐ก๐š๐ง๐, ๐ฏ๐š๐ซ๐ข๐จ๐ฎ๐ฌ ๐œ๐จ๐ฅ๐ฅ๐š๐›๐จ๐ซ๐š๐ญ๐ข๐จ๐ง๐ฌ, ๐ฉ๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ๐ฌ, ๐š๐ง๐ ๐š๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐›๐ž๐ญ๐ฐ๐ž๐ž๐ง ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐š๐ง๐ ๐ฌ๐ฆ๐š๐ซ๐ญ ๐ข๐ง๐ก๐š๐ฅ๐ž๐ซ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ ๐ง๐ž๐ฐ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ข๐ง๐  ๐ฒ๐ž๐š๐ซ๐ฌ.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž:ย https://www.alliedmarketresearch.com/request-sample/1715

๐“๐จ๐ฉ ๐’๐ฆ๐š๐ซ๐ญ ๐ˆ๐ง๐ก๐š๐ฅ๐ž๐ซ ๐Œ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ: –

โ€ข Adherium Limited
โ€ข Aptar Group Inc. (Cohero Health Inc.)
โ€ข AstraZeneca, Inc.
โ€ข Cognita Labs, LLC
โ€ข GlaxoSmithKline Plc
โ€ข Novartis AG
โ€ข OPKO Health Inc.
โ€ข Philip Morris International Inc. (Vectura Group Plc)
โ€ข Resmed Inc. (Propeller Health)
โ€ข Teva Pharmaceutical Industries Ltd.

๐’๐ฆ๐š๐ซ๐ญ ๐ˆ๐ง๐ก๐š๐ฅ๐ž๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

Based on indication, the asthma segment held the highest market share in 2020, accounting for more than half of the global smart inhalers market, and is estimated to maintain its leadership status throughout the forecast period, owing to increasing cases of asthma patients. Moreover, the COPD segment is projected to manifest the highest CAGR of 25.4% from 2021 to 2030, owing to increasing cases of patients suffering from chronic obstructive pulmonary disease (COPD).

Based on distribution channel, the retail pharmacies segment accounted for the largest share in 2020, contributing to nearly three-fifths of the global smart inhalers market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 25.4% from 2021 to 2030, owing to ease of availability of wide range of inhalers in the retail pharmacies.

Based on region, North America held the highest market share in terms of revenue 2020, accounting for nearly two-fifths of the global smart inhalers market. This is owing to rise in respiratory diseases, rapid adoption of advanced technologies and presence of key players across North America. Moreover, the Asia-Pacific region is expected to witness the fastest CAGR of 27.4% during the forecast period, owing to rapidly growing patient pool, increase in publicโ€“private investments, and rise in number of strategic developments among the key players.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.alliedmarketresearch.com/purchase-enquiry/1715

Our Market Research Solution Provides You Answer to Below Mentioned Question:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
  • How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
  • Which region has more opportunities?

By Region Outlook

  • North America

(U.S., Canada, Mexico)

  • Europe

(Germany, France, UK, Italy, Spain, Rest of Europe)

  • Asia-Pacific

(Japan, China, India, Rest of Asia-Pacific)

  • LAMEA

(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa

USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022

[email protected]

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Allied Market Research

Allied Market Research

Allied Market Research (AMR) is approved by the Newstrail editorial board to share timely, data-driven insights. As a trusted leader in market research and analysis across multiple industries, AMR delivers in-depth reports and expert commentary to help businesses stay ahead of emerging trends.

More from Newstrail.com